Inspire Medical Systems appoints Michael H. Carrel, AtriCure CEO, to its board
Inspire Medical Systems appointed Michael H. Carrel to its Board of Directors effective immediately on July 20, 2026, as a Class III director with a term expiring at the 2027 Annual Meeting. Mr. Carrel is president, chief executive officer and a director of AtriCure, Inc., and he was also named to the Organization and Compensation Committee and the Quality, Product Supply and Technology Committee.
Key points
- Board appointment effective immediately, made July 20, 2026, on the recommendation of the Nominating and Corporate Governance Committee
- Mr. Carrel has been CEO of AtriCure, Inc. (NASDAQ: ATRC) since November 2012
- Director compensation includes a $55,000 annual cash retainer, a $300,000 initial restricted stock unit award vesting over three years, and a $200,000 annual restricted stock unit award
- Committee retainers of $7,500 each apply for the Organization and Compensation Committee and the Quality, Product Supply and Technology Committee
The filing
Written by AI on Nov 8, 2026, 1:54 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 24, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.